NCT06949319View on ClinicalTrials.gov

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 16, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New OnsetNon Valvular Atrial FibrillationStroke (in Patients With Atrial Fibrillation)StrokeThrombosis
Trial Locations (1)

6700

RECRUITING

Esbjerg Hospital - University Hospital of Southern Denmark, involving collaboration between the Unit for Thrombosis Research, Department of Clinical Diagnostics and the Department of Cardiology., Esbjerg

All Listed Sponsors
collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

collaborator

Karola Jørgensens Foundation and Foundation for Cardiology in Southwest Denmark.

UNKNOWN

collaborator

Grosserer L.F. Foghts Foundation

UNKNOWN

collaborator

Direktør Kurt Bønnelycke og Hustru fru Grethe Bønnelyckes Fond

UNKNOWN

collaborator

The Faculty of Health Sciences SDU

UNKNOWN

collaborator

Research Electronic Data Capture (REDCap)

UNKNOWN

collaborator

Region of Southern Denmark

OTHER

lead

Nedim Tojaga

OTHER